The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

CORONARY INTERVENTIONS

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

EuroIntervention 2016;12:1090-1101 published online ahead of print September 2016. DOI: 10.4244/EIJY16M09_01

1. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 2. Academic Medical Center, Amsterdam, The Netherlands; 3. Kyoto University Hospital, Kyoto, Japan; 4. Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan; 5. Department of C

Aims: We sought to investigate two-year clinical and serial optical coherence tomography (OCT) outcomes after implantation of a fully bioresorbable vascular scaffold (BVS) or a cobalt-chr

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial